or Try an Advanced Search...

    Muscle Diseases Stocks List

    Symbol Grade Name % Change
    DYN F Dyne Therapeutics, Inc. -6.33
    REGN F Regeneron Pharmaceuticals, Inc. -3.28
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Muscle Disease Angiogenesis Antibodies Asthma Atopic Dermatitis Biopharmaceutical Biotechnology Bone Breakthrough Therapy Cardiovascular Disease Cartilage Cholesterol Clinical Development Clinical Research Colorectal Cancer Dermatitis Disease Disorders Duchenne Duchenne Muscular Dystrophy

    Related ETFs - A few ETFs which own one or more of the above listed Muscle Diseases stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 6.9
    IBB D iShares Nasdaq Biotechnology Index Fund 5.88
    IBBQ D Invesco Nasdaq Biotechnology ETF 5.87
    MNTL F Tema Neuroscience and Mental Health ETF 5.7
    CANC D Tema Oncology ETF 4.87
    View all Muscle Diseases ETFs...
    Compare ETFs
    Compare BBH to CANC Compare IBBQ to CANC Compare MNTL to CANC

        Muscle Diseases Stocks Recent News

        Date Stock Title
        Nov 15 REGN FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
        Nov 15 REGN Regeneron, Sanofi say resubmitted application to expand Dupixent label accepted in U.S.
        Nov 15 REGN Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
        Nov 14 REGN Citi initiates coverage on 5 new biotech stocks
        Nov 14 REGN 2 Top Growth Stocks to Buy on the Dip
        Nov 13 REGN Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
        Nov 13 REGN Regeneron to Highlight Pioneering Pipeline Progress Across Multiple Modalities Spanning 10 Types of Blood Cancers and Disorders at ASH
        Nov 12 DYN Dyne Therapeutics GAAP EPS of -$0.96 misses by $0.25
        Nov 12 DYN Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
        Nov 11 DYN Dyne Therapeutics' Q3 Preview: High-Risk, High-Reward Path In Muscle Diseases
        Nov 11 REGN Regeneron Announces Investor Conference Presentations
        Related Industries: Biotechnology
        Related Stock Lists: Muscle Disease Angiogenesis Antibodies Asthma Atopic Dermatitis Biopharmaceutical Biotechnology Bone Breakthrough Therapy Cardiovascular Disease Cartilage Cholesterol Clinical Development Clinical Research Colorectal Cancer Dermatitis Disease Disorders Duchenne Duchenne Muscular Dystrophy
        Muscle Diseases

        Muscle diseases are conditions that affect the body's muscles. These diseases can cause weakness, pain, and stiffness in the muscles, as well as problems with movement. Some muscle diseases are caused by genetic mutations, while others are caused by lifestyle factors such as poor nutrition or lack of exercise. Treatment for muscle diseases may include physical therapy, medications, and lifestyle changes.

        Browse All Tags